arrow
K

Kaori Miwa

national cerebral and cardiovascular center
H指数:24
被引数:2,354

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Intracranial Atherosclerosis and Cerebral Small Vessel Disease on Overt Vascular Events During Antithrombotic Therapy

颅内动脉粥样硬化和脑小血管病对抗栓治疗期间显性血管事件的影响

2026-06-020
OA
Cilostazol Contributes to Risk Reduction of Stroke Recurrence without Mediating a Reduction of Blood Pressure: Results from CSPS.com

西洛他唑通过不介导血压降低的方式,对降低卒中复发风险有贡献:CSPS.com研究的结果

2025-12-010
PRE
Associations between fluid-attenuated inversion recovery vessel hyperintensities and Alberta stroke program early CT score and clinical outcomes in stroke patients with unknown time of onset: A sub-analysis from a randomized controlled trial

流体衰减反转恢复序列血管高信号与阿尔伯塔卒中计划早期CT评分及临床结局在发病时间不明的卒中患者中的关联:一项随机对照试验的亚组分析

2025-08-300
PRE
Effect of renal function on dual antiplatelet therapy using cilostazol for stroke prevention: a CSPS.com trial post hoc analysis

肾功能对使用西洛他唑进行双联抗血小板治疗预防卒中的影响:CSPS.com试验事后分析

2025-08-180
PRE
Increased risk of recurrent stroke in patients with impaired kidney function: results of a pooled analysis of individual patient data from the MICON international collaboration
2025-04-010
PRE
Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy: Post hoc analysis of the EOS individual participant data

先前抗血小板治疗后静脉注射阿替普酶治疗不明卒中的疗效和安全性: EOS个体参与者数据的事后分析

2025-02-270
PRE
Effects of sex on imaging-based intravenous thrombolysis for ischaemic stroke with unknown onset time: a pooled analysis of clinical trials

性别对以影像学为基础的静脉溶栓治疗发病时间不明的缺血性卒中的影响: 临床试验的汇总分析

2025-01-031
PRE
Thrombolysis for Wake-Up Stroke Versus Non-Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis

唤醒性卒中与非唤醒性未目睹卒中的溶栓治疗: EOS个体患者数据的Meta分析

STROKE
IF8.9
2024-04-013
PRE
Cerebral Small Vessel Disease Burden for Bleeding Risk during Antithrombotic Therapy: Bleeding with Antithrombotic Therapy 2 Study
2024-01-182
OAAI